Cover Image

Real World Experience of Disease Activity in Patients With Rheumatoid Arthritis and Response to Treatment With Varios Biologic DMARDs

The current study investigate the disease activity and effectiveness of treatment in patients with RA on biological disease modifying antirheumatic drugs (bDMARDs) in combination with a conventional synthetic DMARD (csDMARD) and determine whether or not the benefits of different therapies were susta...

Full description

Saved in:

Bibliographic Details
Main Authors:	Vladimira Boyadzhieva (Author), Nikolay Stoilov (Author), Mariana Ivanova (Author), Guenka Petrova (Author), Rumen Stoilov (Author)
Format:	Book
Published:	Frontiers Media S.A., 2018-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Quality of Life and Cost Study of Rheumatoid Arthritis Therapy With Biological Medicines
by: Vladimira V. Boyadzieva, et al.
Published: (2018)

Did the Introduction of Biosimilars Influence Their Prices and Utilization? The Case of Biologic Disease Modifying Antirheumatic Drugs (bDMARD) in Bulgaria
by: Konstantin Tachkov, et al.
Published: (2021)

Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity
by: Juthamas Prawjaeng, et al.
Published: (2023)

Effect of immunomodulating treatment (usage of DMARDs) in rheumatoid arthritis on depression
by: Magdalena Kozyra, et al.
Published: (2020)

Healthcare professionals' perceptions on barriers and facilitators to DMARD use in rheumatoid arthritis
by: M. J. H. Voshaar, et al.
Published: (2022)

CORRELATIONS BETWEEN SYSTEMIC THERAPY WITH CONVENTIONAL (SYNTHETIC) AND BIOLOGICAL DMARDS, RHEUMATOID ARTHRITIS AND PERIODONTAL INDICES OF CHRONIC PERIODONTITIS
by: Maria Alexandra Martu, et al.
Published: (2019)

Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies
by: Ferrufino CP, et al.
Published: (2018)

Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis
by: Maria Chiara Gerardi, et al.
Published: (2022)

Real-world effectiveness of biological therapy in patients with rheumatoid arthritis: Systematic review and meta-analysis
by: Caroline Tianeze de Castro, et al.
Published: (2022)

Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies [Corrigendum]
by: Ferrufino CP, et al.
Published: (2019)

Varicella immunity and vaccine response in children with juvenile idiopathic arthritis treated with DMARD
by: Nordal EB, et al.
Published: (2011)

The Efficacy and Safety of Mainstream Medications for Patients With cDMARD-Naïve Rheumatoid Arthritis: A Network Meta-Analysis
by: Weiyan Cai, et al.
Published: (2018)

Comparative Price Analysis of Biological Products for Treatment of Rheumatoid Arthritis
by: Manoela Manova, et al.
Published: (2018)

Saudi cultural adaptation of the "compliance questionnaire of Rheumatology" for Rheumatoid arthritis patients on disease modifying anti-rheumatic drugs (DMARDs)
by: Roaa Aljohani, et al.
Published: (2021)

Disease Activity in Disease Modifying Anti-Rheumatic Drug (DMARD) Naïve Rheumatoid Arthritis Patients in A Subset of Karachi Population
by: Dr. Mehreen Inam Illahi, et al.
Published: (2024)

Targeting MyD88 Downregulates Inflammatory Mediators and Pathogenic Processes in PBMC From DMARDs-Naïve Rheumatoid Arthritis Patients
by: Sergio Ramirez-Perez, et al.
Published: (2021)

Efficacy of the cardiac glycoside digoxin as an adjunct to csDMARDs in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled trial
by: Nageh A. El-Mahdy, et al.
Published: (2024)

Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis
by: Van De Laar CJ, et al.
Published: (2020)

Efficacy and safety of tofacitinib in rheumatoid arthritis: Nine years of real‐world data
by: Ali Ekin, et al.
Published: (2024)

Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis
by: Howard Busch, et al.
Published: (2022)

Real-world clinical outcomes and rationale for initiating abatacept as a first-line biologic for patients with anticitrullinated protein antibody- and rheumatoid factor-positive rheumatoid arthritis
by: Alexandrina Balanean, et al.
Published: (2024)

Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs
by: E. Lubrano, et al.
Published: (2012)

Implant-Retained Prosthetic Rehabilitation of a Patient with Severe Oral Lichen Sclerosus
by: Tim Kluenter, et al.
Published: (2023)

Exploring drug cost and disease outcome in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs in Norway in 2010-2019 - a country with a national tender system for prescription of costly drugs
by: Alen Brkic, et al.
Published: (2022)

Efficacy of Virtual Preparation Simulators Compared to Traditional Preparations on Phantom Heads
by: Lea Stoilov, et al.
Published: (2024)

Perioperative Management of Patients with Rheumatic Diseases: Glucocorticoids, DMARDs, Biological Agents and NSAIDs
by: V. V. Lyalina, et al.
Published: (2022)

An open randomized active-controlled clinical trial with low-dose SKA cytokines versus DMARDs evaluating low disease activity maintenance in patients with rheumatoid arthritis
by: Martin-Martin LS, et al.
Published: (2017)

Clinical remission of rheumatoid arthritis in a multicenter real-world study in Asia-Pacific region
by: Xing Sun, et al.
Published: (2021)

Adverse Events in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Receiving Long-Term Biological Agents in a Real-Life Setting
by: Mayara Costa de Camargo, et al.
Published: (2019)

Antologia grega. Epigramas Vários
by: Carlos A. Martins de Jesus
Published: (2018)

Persistence and Safety of Golimumab in Elderly Patients with Rheumatoid Arthritis and Renal Dysfunction in a Real-World Setting
by: Seiji Yokoyama, et al.
Published: (2022)

Construindo brincadeiras e conhecimentos: relatos de uma experiência nas séries iniciais do ensino fundamental
by: Raquel Stoilov Pereira, et al.
Published: (2011)

Desafios impostos às aulas de educação física na pandemia: caminhos para a ressignificação do trabalho docente
by: Evando Carlos Moreira, et al.
Published: (2021)

The plasma Tumor Necrosis Factor-α (TNF-α) does not have any correlation with disease activity in rheumatoid arthritis patients treated with disease modifying anti-rheumatic drugs (DMARDs)
by: Zahra Samimi, et al.
Published: (2020)

Proton therapy for head and neck cancer therapy: A real-world data case study from Bulgaria
by: Maria Dimitrova, et al.
Published: (2024)

The combination of Chinese and Western Medicine in the management of rheumatoid arthritis: A real-world cohort study across China
by: Linda LD. Zhong, et al.
Published: (2022)

Correction: Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry
by: Timothy Hahn, et al.
Published: (2022)

¿Uno solo o varios mundos?
by: Mónica Zuleta Pardo, Humberto Cubides, Manuel Roberto Escobar (dir.)
Published: (2007)

Emerging intervention of antidepressant with DMARD in non-cancerous nociceptive persistent pain associated depression in FCA induced rheumatoid arthritic rats
by: Sudhakar Pachiappan, et al.
Published: (2021)

Adherence to Acromegaly Treatment and Analysis of the Related Factors-A Real-World Study in Bulgaria
by: Maria Kamusheva, et al.
Published: (2023)